{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:38:13Z","timestamp":1790692693823,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T00:00:00Z","timestamp":1729209600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","award":["217461"],"award-info":[{"award-number":["217461"]}],"id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.anai.2024.10.015","type":"journal-article","created":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T07:04:36Z","timestamp":1729321476000},"page":"685-693.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Quantifying corticosteroid burden in chronic rhinosinusitis with nasal polyps"],"prefix":"10.1016","volume":"134","author":[{"given":"Joseph K.","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared","family":"Silver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indu","family":"Dhangar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phani","family":"Veeranki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arijita","family":"Deb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anai.2024.10.015_bib0001","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1146\/annurev-pathol-052016-100401","article-title":"Immunopathogenesis of chronic rhinosinusitis and nasal polyposis","volume":"12","author":"Schleimer","year":"2017","journal-title":"Annu Rev Pathol"},{"issue":"4","key":"10.1016\/j.anai.2024.10.015_bib0002","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jaip.2016.04.012","article-title":"Chronic rhinosinusitis with nasal polyps","volume":"4","author":"Stevens","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.anai.2024.10.015_bib0003","doi-asserted-by":"crossref","first-page":"82","DOI":"10.4193\/Rhin20.601","article-title":"Executive summary of EPOS 2020 including integrated care pathways","volume":"58","author":"Fokkens","year":"2020","journal-title":"Rhinology"},{"issue":"1","key":"10.1016\/j.anai.2024.10.015_bib0004","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jaci.2020.11.013","article-title":"EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics: definitions and management","volume":"147","author":"Bachert","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2024.10.015_bib0005","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/alr.22741","article-title":"International consensus statement on allergy and rhinology: rhinosinusitis 2021","volume":"11","author":"Orlandi","year":"2021","journal-title":"Int Forum Allergy Rhinol"},{"issue":"3","key":"10.1016\/j.anai.2024.10.015_bib0006","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/lary.26391","article-title":"Prevalence of polyp recurrence after endoscopic sinus surgery for chronic rhinosinusitis with nasal polyposis","volume":"127","author":"DeConde","year":"2017","journal-title":"Laryngoscope"},{"issue":"6","key":"10.1016\/j.anai.2024.10.015_bib0007","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s40629-022-00220-x","article-title":"Indicating biologics for chronic rhinosinusitis with nasal polyps (CRSwNP)","volume":"31","author":"Klimek","year":"2022","journal-title":"Allergo J Int"},{"issue":"2","key":"10.1016\/j.anai.2024.10.015_bib0008","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/0145561319876906","article-title":"Oral corticosteroid regimens in the management of chronic rhinosinusitis","volume":"101","author":"Mansi","year":"2022","journal-title":"Ear Nose Throat J"},{"key":"10.1016\/j.anai.2024.10.015_bib0009","unstructured":"Global Initiative for Asthma. Global strategy for asthma management and prevention. Accessed May 2, 2024. Available at: https:\/\/ginasthma.org\/wp-content\/uploads\/2023\/05\/GINA-2023-Full-Report-2023-WMS.pdf."},{"issue":"3","key":"10.1016\/j.anai.2024.10.015_bib0010","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1164\/rccm.201904-0903SO","article-title":"Systematic literature review of systemic corticosteroid use for asthma management","volume":"201","author":"Bleecker","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.anai.2024.10.015_bib0011","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2147\/JAA.S176026","article-title":"Adverse outcomes from initiation of systemic corticosteroids for asthma: long-term observational study","volume":"11","author":"Price","year":"2018","journal-title":"J Asthma Allergy"},{"key":"10.1016\/j.anai.2024.10.015_bib0012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13601-019-0303-6","article-title":"Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper","volume":"10","author":"Hox","year":"2020","journal-title":"Clin Transl Allergy"},{"issue":"4","key":"10.1016\/j.anai.2024.10.015_bib0013","doi-asserted-by":"crossref","DOI":"10.1177\/2473974X221128930","article-title":"Elucidating the real-world burden of chronic rhinosinusitis with nasal polyps in patients in the USA","volume":"6","author":"Benson","year":"2022","journal-title":"OTO Open"},{"key":"10.1016\/j.anai.2024.10.015_bib0014","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.2147\/JAA.S378469","article-title":"Profiling disease and economic burden in CRSwNP using machine learning","volume":"15","author":"Bhattacharyya","year":"2022","journal-title":"J Asthma Allergy"},{"issue":"9","key":"10.1016\/j.anai.2024.10.015_bib0015","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.clinthera.2022.08.004","article-title":"Systemic corticosteroid-related adverse outcomes and health care resource utilization and costs among patients with chronic rhinosinusitis with nasal polyposis","volume":"44","author":"Davis","year":"2022","journal-title":"Clin Ther"},{"issue":"2","key":"10.1016\/j.anai.2024.10.015_bib0016","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1159\/000518514","article-title":"Overuse of oral corticosteroids, underuse of inhaled corticosteroids, and implications for biologic therapy in asthma","volume":"101","author":"Eger","year":"2022","journal-title":"Respiration"},{"key":"10.1016\/j.anai.2024.10.015_bib0017","unstructured":"US Department of Labor. Consumer price index.for All Urban Consumers (CPI-U): U.S. city average, medical care - CUUR0000SAM. Accessed May 2, 2024. Available at: https:\/\/data.bls.gov\/cgi-bin\/surveymost?cu."},{"issue":"6","key":"10.1016\/j.anai.2024.10.015_bib0018","doi-asserted-by":"crossref","first-page":"897","DOI":"10.3390\/jpm12060897","article-title":"Survey on use of local and systemic corticosteroids in the management of chronic rhinosinusitis with nasal polyps: identification of unmet clinical needs","volume":"12","author":"De Corso","year":"2022","journal-title":"J Pers Med"},{"issue":"7","key":"10.1016\/j.anai.2024.10.015_bib0019","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.rmed.2009.01.003","article-title":"The cumulative burden of oral corticosteroid side effects and the economic implications of steroid use","volume":"103","author":"Manson","year":"2009","journal-title":"Respir Med"},{"key":"10.1016\/j.anai.2024.10.015_bib0020","doi-asserted-by":"crossref","first-page":"j1415","DOI":"10.1136\/bmj.j1415","article-title":"Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study","volume":"357","author":"Waljee","year":"2017","journal-title":"BMJ"},{"issue":"12","key":"10.1016\/j.anai.2024.10.015_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2022.100726","article-title":"Systemic corticosteroids in asthma: a call to action from World Allergy Organization and Respiratory Effectiveness Group","volume":"15","author":"Bleecker","year":"2022","journal-title":"World Allergy Organ J"},{"issue":"1","key":"10.1016\/j.anai.2024.10.015_bib0022","first-page":"85","article-title":"Antibiotic prophylaxis in otolaryngologic surgery","volume":"17","author":"Ottoline","year":"2013","journal-title":"Int Arch Otorhinolaryngol"},{"issue":"9","key":"10.1016\/j.anai.2024.10.015_bib0023","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1016\/j.jaip.2023.05.011","article-title":"The unified airway hypothesis: evidence from specific intervention with anti-IL-5 biologic therapy","volume":"11","author":"Bachert","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.anai.2024.10.015_bib0024","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2217\/imt-2019-0191","article-title":"Dupilumab in the treatment of chronic rhinosinusitis with nasal polyposis","volume":"12","author":"Boyle","year":"2020","journal-title":"Immunotherapy"},{"issue":"3","key":"10.1016\/j.anai.2024.10.015_bib0025","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.jaip.2020.08.039","article-title":"Clinical development of mepolizumab for the treatment of severe eosinophilic asthma: on the path to personalized medicine","volume":"9","author":"Pavord","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.anai.2024.10.015_bib0026","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/alr.22487","article-title":"Revision surgery rates in chronic rhinosinusitis with nasal polyps: meta-analysis of risk factors","volume":"10","author":"Loftus","year":"2020","journal-title":"Int Forum Allergy Rhinol"},{"issue":"6","key":"10.1016\/j.anai.2024.10.015_bib0027","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.jaip.2022.02.017","article-title":"BioLogicals and endoscopic sinus surgery for severe uncontrolled chronic rhinosinusitis with nasal polyps: an economic perspective","volume":"10","author":"van der Lans","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"11","key":"10.1016\/j.anai.2024.10.015_bib0028","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1016\/j.jaip.2023.08.015","article-title":"Mepolizumab reduces systemic corticosteroid use in chronic rhinosinusitis with nasal polyps","volume":"11","author":"Chupp","year":"2023","journal-title":"J Allergy Clin Immunol Pract"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120624015746?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120624015746?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T12:23:30Z","timestamp":1778588610000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120624015746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S1081120624015746"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2024.10.015","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantifying corticosteroid burden in chronic rhinosinusitis with nasal polyps","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2024.10.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}